MedPath

FZ-AD004

Generic Name
FZ-AD004

A Study of FZ-AD004 in Patients With Advanced Solid Tumors

Phase 1
Recruiting
Conditions
Advanced and Metastatic Solid Tumor
Interventions
First Posted Date
2023-06-22
Last Posted Date
2024-05-17
Lead Sponsor
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Target Recruit Count
121
Registration Number
NCT05914545
Locations
🇨🇳

Shanghai Chest Hospital, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath